Polamarasetty Aparoy

Polamarasetty Aparoy

Auto-generated profile, based on publicly available information

Polamarasetty Aparoy

Molecular Modeling and Protein Engineering Lab, Biology Division, Indian Institute of Petroleum and Energy, Visakhapatnam, India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2010 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
BKBhusan K Kuntal
Bhusan K Kuntal
PAPolamarasetty Aparoy
Polamarasetty Aparoy
PRPallu Reddanna
Pallu Reddanna
MODELLER is a program for automated protein Homology Modeling. It is one of the most widely used tool for homology or comparative modeling of protein three-dimensional structures, but most users find it a bit difficult to start with MODELLER as it is command line based and requires knowledge of basic Python scripting to use it efficiently.

1 June 2012 in Current Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
PAPolamarasetty Aparoy
Polamarasetty Aparoy
KRKakularam Kumar Reddy
Kakularam Kumar Reddy
PRPallu Reddanna
Pallu Reddanna
Lipoxygenases (LOXs) are non-heme iron containing dioxygenases involved in the oxygenation of polyunsaturated fatty acids (PUFAs) such as arachidonic acid (AA). Depending on the position of insertion of oxygen, LOXs are classified into 5-, 8-, 9-, 12- and 15-LOX. Among these, 5-LOX is the most predominant isoform associated with the formation of 5-hydroperoxyeicosatetraenoic acid (5- HpETE), the precursor of non-peptido (LTB4) and peptido (LTC4, LTD4, and LTE4) leukotrienes. LTs are involved in inflammatory and allergic diseases like asthma, ulcerative colitis, rhinitis and also in cancer. Consequently 5-LOX has become target for the development of therapeutic molecules for treatment of various inflammatory disorders. Zileuton is one such inhibitor of 5-LOX approved for the treatment of asthma. In the recent times, computer aided drug design (CADD) strategies have been applied successfully in drug development processes. A comprehensive review on structure based drug design strategies in the development of novel 5-LOX inhibitors is presented in this article. Since the crystal structure of 5-LOX has been recently solved, efforts to develop 5-LOX inhibitors have mostly relied on ligand based rational approaches. The present review provides a comprehensive survey on these strategies in the development of 5-LOX inhibitors.

1 January 2015 in Progress in Lipid Research
Verified
Journal Article
Closed access
THThomas Horn
Thomas Horn
SASusan Adel
Susan Adel
RSRalf Schumann
Ralf Schumann
SSSaubashya Sur
Saubashya Sur
KKKumar Reddy Kakularam
Kumar Reddy Kakularam
DHDagmar Heydeck
Dagmar Heydeck

31 May 2014 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
MRM. Rami Reddy
M. Rami Reddy
CRC. Ravikumar Reddy
C. Ravikumar Reddy
RRRS Rathore
RS Rathore
MEMark D. Erion
Mark D. Erion
PAP. Aparoy
P. Aparoy
PRP. Reddanna
P. Reddanna
Post-genomic era has led to the discovery of several new targets posing challenges for structure-based drug design efforts to identify lead compounds. Multiple computational methodologies exist to predict the high ranking hit/lead compounds. Among them, free energy methods provide the most accurate estimate of predicted binding affinity. Pathway-based Free Energy Perturbation (FEP), Thermodynamic Integration (TI) and Slow Growth (SG) as well as less rigorous end-point methods such as Linear interaction energy (LIE), Molecular Mechanics-Poisson Boltzmann./Generalized Born Surface Area (MM-PBSA/GBSA) and λ-dynamics have been applied to a variety of biologically relevant problems. The recent advances in free energy methods and their applications including the prediction of protein-ligand binding affinity for some of the important drug targets have been elaborated. Results using a recently developed Quantum Mechanics (QM)/Molecular Mechanics (MM) based Free Energy Perturbation (FEP) method, which has the potential to provide a very accurate estimation of binding affinities to date has been discussed. A case study for the optimization of inhibitors for the fructose 1,6- bisphosphatase inhibitors has been described.

1 September 2013 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RFRosanna Filosa
Rosanna Filosa
APAntonella Peduto
Antonella Peduto
PAPolamarasetty Aparoy
Polamarasetty Aparoy
ASAnja M. Schaible
Anja M. Schaible
SLSusann Luderer
Susann Luderer
OWOliver Werz
Oliver Werz

1 August 2010 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
NRNimmanapalli P. Reddy
Nimmanapalli P. Reddy
PAPolamarasetty Aparoy
Polamarasetty Aparoy
TRT. Chandra Mohan Reddy
T. Chandra Mohan Reddy
CAChandrani Achari
Chandrani Achari
PSP. Ramu Sridhar
P. Ramu Sridhar
PRPallu Reddanna
Pallu Reddanna